home.aspx
 
EVENTS

SiriusDecisions 2019 Technology Exchange
SIRIUSDECISIONS 2019 TECHNOLOGY EXCHANGE
December 09-11, 2019
The drive for growth never ceases for b-to-b organizations, and more than ever technology is at the centre of enabling that progress. Gone are the days however when a disparate, disconnected set of platforms strewn across sales, marketing an product can serve the organization effectively. An aligned...

eyeforpharma Awards 2019
EYEFORPHARMA AWARDS 2019
December 11-11, 2019
You’ll already know if you’re a winner: your patients are telling you. But now it’s time to be recognised by your peers and the wider healthcare community. The eyeforpharma awards are unique. They’re the only awards that focus exclusively on what matters - value for patients ...

Avella Specialty Pharmacy

Avella's mission is to optimize patient health through a relentless devotion to clinical excellence. This philosophy is the primary reason we’ve become a leader in the specialty pharmacy industry.

RELATED NEWS


A ranking of pharma companies developing new medicines for low- and middle-income countries has revealed that just five companies are responsible for almost two-thirds of projects. The heroes in the 2018 Access to Medicine Index for conducting high-priority R&D are GlaxoSmithKline, Johnson & Johnson, Sanofi, Merck KGaA and Novartis, with GSK topping the chart of top 20 pharma companies for the sixth year running. At the other end of the scale are Novo Nordisk, Boehringer Ingelheim, Eli L...

READ MORE

In January, Takeda Pharmaceutical announced plans to sell about $10 billion worth of assets to offset some of the debt the company garnered in its $62 billion acquisition of Shire. On Wednesday, the Osaka, Japan company announced divestitures worth about $5.7 billion. Takeda entered into agreements with Swiss pharma giant Novartis and Ethicon. Novartis agreed to acquire Xiidra (lifitegrast ophthalmic solution) 5% product for $3.4 billion up front in cash and up to an additional $1.9 billion in p...

READ MORE

Grappling with a backlash against high U.S. prescription drug prices, more pharmaceutical companies are pledging to limit annual increases to under 10 percent - but the tactic is doing little to salve critics, including President-elect Donald Trump, who on Wednesday said drugmakers are "getting away with murder....

READ MORE

Artificial intelligence (AI) technology is already beginning to have an impact in medicine, but there’s certainly a lot more than we should be expecting from it in the future. There are a number of issues that prevent a wider adoption of AI in medicine, a lot of the technological in nature. For example, medical systems can produce vast quantities of data and a lot of the data may be coming from old, slow systems that were never expected to interface with modern computer platforms. Moreover...
NVIDIA
READ MORE

Representative images of lungs treated with gene therapy vectors. The nuclei are in blue, alveolar type II cells in green and telomeres in red. Notice that lung cells treated with active telomerase present more intense telomeres indicating that they are longer as compared to lung cells treated with the null vectors or with an inactive telomerase. Credit: CNIO. Negative results and findings in science are perhaps less newsworthy, but they are no less important. Particularly when, as in this case,...

READ MORE

Bigtincan (ASX:BTH), the leader in mobile, AI-powered sales enablement automation, today announced the acquisition of Veelo Inc., a pioneer in sales enablement, to expand Bigtincan’s presence and offerings in the technology market vertical. The combination of Bigtincan’s solution, designed with the mobile-first user in mind, and Veelo’s focus on traditional sales enablement with key enhancements for desktop and web solutions, will augment and compliment the different ways sales...
SOURCE
READ MORE

EVENTS

SiriusDecisions 2019 Technology Exchange
SIRIUSDECISIONS 2019 TECHNOLOGY EXCHANGE
December 09-11, 2019
The drive for growth never ceases for b-to-b organizations, and more than ever technology is at the centre of enabling that progress. Gone are the days however when a disparate, disconnected set of platforms strewn across sales, marketing an product can serve the organization effectively. An aligned...

eyeforpharma Awards 2019
EYEFORPHARMA AWARDS 2019
December 11-11, 2019
You’ll already know if you’re a winner: your patients are telling you. But now it’s time to be recognised by your peers and the wider healthcare community. The eyeforpharma awards are unique. They’re the only awards that focus exclusively on what matters - value for patients ...